Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

10.85
Delayed Data
As of Jun 21
 -0.10 / -0.91%
Today’s Change
8.55
Today|||52-Week Range
13.74
+0.46%
Year-to-Date
Company News for June 09, 2017
Jun 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close10.95
Today’s open10.90
Day’s range10.85 - 11.00
Volume1,561,987
Average volume (3 months)421,420
Market cap$561.3M
Dividend yield--
Data as of 06/21/2017

Growth & Valuation

Earnings growth (last year)+3.57%
Earnings growth (this year)+62.07%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+1.81%
P/E ratio15.3
Price/Sales3.55
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...+0.27+3.93%
ACHNAchillion Pharmaceut...-0.28-6.21%
PGNXProgenics Pharmaceut...+0.45+6.31%
OTICOtonomy Inc+1.45+9.03%
Data as of 06/21/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$160.1M
Annual profit (last year)$30.7M
Net profit margin19.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior VP-Finance
Wai-Shun Cheung
Corporate headquarters
Foster City, California

Forecasts